ReviewMicroorganisms2026
The Versatility of Pomegranate: From Phytochemical Diversity to Antimicrobial and Translational Applications.
Review in Microorganisms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pomegranate is increasingly being recognized as a versatile source of bioactive compounds with antimicrobial, antioxidant, anti-inflammatory, and microbiota-modulating potential. Beyond the edible arils and juice, peel, seeds, leaves, flowers, and other agro-industrial by-products are rich in ellagitannins, particularly punicalagins, as well as ellagic acid, gallic acid, flavonoids, anthocyanins, fatty acids, and related phytochemicals. Their recovery depends strongly on plant fraction, cultivar, solvent, and extraction technology, including conventional hydroalcoholic extraction, ultrasound- and microwave-assisted processes, high-pressure treatments, and enzyme-assisted methods. Pomegranate-derived preparations exhibit activity against Gram-positive and Gram-negative bacteria, fungi, multidrug-resistant pathogens, and microbial biofilms, while selected compounds may enhance the efficacy of conventional antimicrobials. Emerging evidence also indicates bidirectional interactions with microbial communities, including microbial biotransformation of ellagitannins into urolithins and modulation of beneficial taxa and microbial metabolites. This narrative review integrates agronomic and phytochemical diversity, extraction and standardization strategies, mechanisms of antimicrobial action, synergistic interactions, microbiota-related effects, and applications in food preservation, biomedicine, animal nutrition, agriculture, and environmental sustainability. Key translational limitations include compositional variability, methodological heterogeneity, insufficient standardization, limited in vivo validation, and scarce evidence from realistic application models and clinical studies. Addressing these gaps is essential for developing safe, reproducible, and scalable pomegranate-derived preparations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.